Patrick J. Mcenany - Aug 18, 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Patrick J. McEnany
Stock symbol
CPRX
Transactions as of
Aug 18, 2022
Transactions value $
-$3,443,775
Form type
4
Date filed
8/19/2022, 05:02 PM
Previous filing
Feb 16, 2022
Next filing
Sep 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $63.3K +25K +0.51% $2.53* 4.96M Aug 18, 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$348K -25K -0.5% $13.93 4.93M Aug 18, 2022 Direct F1, F6
transaction CPRX Common stock, par value $0.001 per share Options Exercise $127K +50K +1.01% $2.53* 4.98M Aug 18, 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$697K -50K -1% $13.93 4.93M Aug 18, 2022 Direct F2, F6
transaction CPRX Common Stock, par value $0.001 per share Options Exercise $127K +50K +1.01% $2.53* 4.98M Aug 18, 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$698K -50K -1% $13.96 4.93M Aug 18, 2022 Direct F3, F6
transaction CPRX Common stock,. par value $0.001 per share Options Exercise $127K +50K +1.01% $2.53* 4.98M Aug 18, 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$698K -50K -1% $13.95 4.93M Aug 18, 2022 Direct F4, F6
transaction CPRX Common stock, par value $0.001 per share Options Exercise $316K +125K +2.54% $2.53* 5.06M Aug 19, 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$1.76M -125K -2.47% $14.10 4.93M Aug 19, 2022 Direct F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -25K -0.68% $0.00 3.64M Aug 18, 2022 Common Stock 25K $2.53 Direct F7
transaction CPRX Options to purchase common stock Options Exercise $0 -50K -1.37% $0.00 3.59M Aug 18, 2022 Common Stock 50K $2.53 Direct F7
transaction CPRX Options to purchase common stock Options Exercise $0 -50K -1.39% $0.00 3.54M Aug 18, 2022 Common Stock 50K $2.53 Direct F7
transaction CPRX Options to purchase common stock Options Exercise $0 -50K -1.41% $0.00 3.49M Aug 18, 2022 Common Stock 50K $2.53 Direct F7
transaction CPRX Options to purchase common stock Options Exercise $0 -125K -3.58% $0.00 3.37M Aug 19, 2022 Common Stock 125K $2.53 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold in various lots from $13.93 to $13.97 per share. The listed sales price represents a weighted average price for the shares sold.
F2 Shares were sold in various lots from $13.93 to $13.94 per share. The listed sales price represents a weighted average price for the shares sold.
F3 Shares were sold in various lots from $13.95 to $14.00 per share. The listed sales price represents a weighted average price for the shares sold.
F4 Shares were sold in various lots from $13.95 to $13.98 per share. The listed sales price represents a weighted average price for the shares sold.
F5 Shares were sold in various lots from $14.05 to $14.14 per share. The listed sales price represents a weighted average price for the shares sold.
F6 Shares were sold to cover the exercise price of options, tax withholding requirements (if applicable) and for personal reasons. The shares were not sold as a result of any agreement with the Company and Mr. McEnany remains an officer of the company.
F7 Options vested in three separate tranches beginning on December 30, 2016.